Literature DB >> 10597055

The role of pancreaticoduodenectomy in the treatment of severe chronic pancreatitis.

S M Vickers1, C Chan, M J Heslin, A Bartolucci, J S Aldrete.   

Abstract

Chronic pancreatitis remains a debilitating disease with few definitive options for treatment. The purpose of this study was to evaluate the benefit of pancreaticoduodenectomy in the treatment of chronic pancreatitis. The results were evaluated by standard descriptive statistics. In a retrospective study, we reviewed the patients at a single institution undergoing pancreaticoduodenectomy between 1994 and 1997 for complications of chronic pancreatitis. Patients were evaluated for preoperative indication for surgery and perioperative morbidity and mortality, as well as long-term results. Thirty-two patients underwent pancreaticoduodenectomy for chronic pancreatitis; 56 per cent (18) underwent pylorus-preserving and 44 per cent (14) underwent classic pancreaticoduodenectomy. The mean age of these patients was 56+/-14.7 years (range, 23-79). All patients underwent preoperative CT scan and endoscopic retrograde cholangiopancreatography. The preoperative indication for surgery in 81 per cent (26) of these patients was intractable pain in the setting of a nondilated pancreatic duct. The other 19 per cent were treated for biliary/pancreatic duct stricture and pancreatic head fibrosis (mass suspicious of malignancy). Fifty-three per cent of the patients had a history of previous abdominal surgery. There were no perioperative deaths. The mean postoperative stay was 12.2+/-7.4 days. The postoperative morbidity rate was 31 per cent (10), consisting of 25 per cent with delayed gastric emptying, 3 per cent with pneumonia, and 3 per cent with wound infections. There was no occurrence of pancreatic fistulas. With a mean follow-up of 40 months (range, 10-52 months), 85 per cent reported a significant improvement in pain with 71 per cent being pain free and not requiring narcotics. Twenty per cent developed new-onset diabetes. The overall event survival rate at 5 years was 97 per cent. Thus, in a selected group of patients with severe chronic pancreatitis, resection of the head of the pancreas achieved relief of symptoms and was a safe and effective treatment for chronic pancreatitis.

Entities:  

Mesh:

Year:  1999        PMID: 10597055

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

Review 1.  Minimal-access approaches to complications of acute pancreatitis and benign neoplasms of the pancreas.

Authors:  T A Kellogg; K D Horvath
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

2.  Surgical treatment of chronic pancreatitis using Frey's procedure: a Brazilian 16-year single-centre experience.

Authors:  Martinho Antonio Gestic; Francisco Callejas-Neto; Elinton Adami Chaim; Murillo Pimentel Utrini; Everton Cazzo; Jose Carlos Pareja
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

3.  Age comorbidity scores as risk factors for 90-day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population-Based Study.

Authors:  Ben-Chang Shia; Lei Qin; Kuan-Chou Lin; Chih-Yuan Fang; Lo-Lin Tsai; Yi-Wei Kao; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.